BLUE SAIL MEDICAL's subsidiary's next-generation recyclable transcatheter aortic valve replacement delivery system has obtained CE certification

Zhitong
2025.06.27 08:31
portai
I'm PortAI, I can summarize articles.

According to the Zhitong Finance APP, BLUE SAIL MEDICAL announced that its subsidiary, NVTGmbH in the cardiovascular division, has developed a new generation of recyclable transcatheter aortic valve replacement (TAVR) delivery system IMPERIA™ (referred to as "IMPERIA™ delivery system"), which has obtained CE certification from the European Union. This delivery system is used in conjunction with the company's already listed ALLEGRA™ series aortic valves to achieve recyclable functionality

According to the Zhitong Finance APP, BLUE SAIL MEDICAL (002382.SZ) announced that its subsidiary, Germany's NVTGmbH, has developed a new generation of recyclable transcatheter aortic valve replacement (TAVR) delivery system IMPERIA™ (referred to as "IMPERIA™ delivery system"), which has obtained CE certification from the European Union. This delivery system is used in conjunction with the company's already listed ALLEGRA™ series aortic valves to achieve recyclable functionality

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer